Your First Month on a GLP-1: How It Works and What to Expect (2026)

If a licensed provider has prescribed semaglutide or tirzepatide, the first month is when most of the questions show up: how does semaglutide work, where do you inject it, and can you still have a glass of wine? This guide walks through what the first month often looks like, based on the FDA labels and the clinical trials. Your provider's instructions always come first, and results vary from person to person.

Key takeaways

• Semaglutide mimics the gut hormone GLP-1, and tirzepatide acts on both GIP and GLP-1 receptors; both slow stomach emptying and affect appetite signals.
• The first month is spent on a starting dose that the provider increases gradually, so early changes are often modest and digestive effects are common.
• Injection sites are the abdomen, thigh or upper arm; rotate sites and follow the Instructions for Use that come with your product.
• The labels do not prohibit alcohol, but alcohol can worsen nausea and adds calories, so talk with your provider about it.

How does semaglutide work?

Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone your gut releases after you eat. It helps the pancreas release insulin when blood sugar rises, slows how fast food leaves the stomach, and acts on areas of the brain involved in appetite. Semaglutide is built to mimic that hormone and to last much longer in the body, which is why it is injected once a week.

In practice, many patients describe 3 changes: feeling full sooner, feeling full longer, and thinking about food less often. Semaglutide is indicated, alongside a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain that reduction long term. In the STEP 1 trial, the average reduction in body weight over 68 weeks with lifestyle changes was 14.9% with semaglutide, compared with 2.4% with placebo. That is a study average, not a prediction: individual results vary.

How does tirzepatide work?

Tirzepatide acts on 2 receptors instead of 1: the GLP-1 receptor and the GIP receptor. GIP is another gut hormone released after meals, and the 2 signals together appear to affect appetite and how the body handles food. Tirzepatide is also injected once a week.

In the SURMOUNT-1 trial, the average reduction in body weight over 72 weeks with lifestyle changes was 15.0% to 20.9% depending on the tirzepatide dose, compared with 3.1% with placebo. These are study averages; individual results vary, and a licensed provider decides which medication, if any, fits your health history. Our semaglutide vs. tirzepatide guide compares them in detail.

How does semaglutide work in the first month?

The FDA labels for both medications call for a low starting dose that the provider raises step by step over several months. The starting dose exists to let your digestive system adjust, not to produce big results, so the first month on semaglutide or tirzepatide is usually about settling in. Here are patterns many patients report, with the caution that yours may look different.

Week 1. The first injection is often uneventful. Some people notice a smaller appetite within a day or 2; others notice nothing. Mild nausea or early fullness can appear, especially after a large or fatty meal.

Week 2. Appetite changes tend to become more noticeable, and portions that once felt normal may feel like too much. Nausea, constipation or loose stools are among the most common side effects in the labels.

Week 3. Many people have found a rhythm with smaller meals. Energy can dip for some, often because they are eating and drinking less than they realize.

Week 4. By now you may have a sense of how your body responds to the starting dose. The scale may have moved a little, a lot, or not at all, and all 3 are normal at this stage. Your provider reviews how you are doing before deciding whether and when to increase the dose.

Where to inject: semaglutide injection sites and tirzepatide

The labels for Wegovy® and Zepbound® list the same 3 injection areas: the abdomen, the thigh and the upper arm. The Zepbound® label says the back of the upper arm should be injected by another person. The injection goes under the skin, not into muscle. Brand names are trademarks of their respective owners; Forever Health Rx is not affiliated with them.

A few rules from the Wegovy® Instructions for Use and Medication Guide are a good general guide; always follow the instructions for your own product:

• Rotate. Use a different spot each week, and if you stay in the same area, move away from the last spot so the skin can recover.
• Avoid skin that is bruised, tender, red, hard or scarred, and stay at least 2 inches away from the belly button if you inject in the abdomen.
• Wash your hands and clean the site with an alcohol swab or soap and water.
• Never share a pen, vial, needle or syringe with anyone, even if the needle is changed. Both labels carry a "never share" warning for pens.
• Follow the pharmacy's and your provider's instructions for the specific product you received. Pens and vials are handled differently.

Where to inject tirzepatide is the same as for semaglutide: abdomen, thigh or upper arm. Used needles and pens go in an FDA-cleared sharps container or, if one is not available, a heavy-duty plastic household container with a tight-fitting, puncture-resistant lid, never loose in the trash or in recycling. The FDA's sharps page explains the options, and local rules decide how to dispose of the full container.

Injection day tips

Pick a day of the week that is easy to remember and keep it. Both labels allow the injection at any time of day, with or without food. The injection day can be changed as long as enough time has passed since the last dose (at least 2 days for Wegovy®, per its Medication Guide, and at least 3 days for Zepbound®, per its label); ask your provider first.

If you miss a dose, the labels give general rules. For Wegovy®, take the missed dose as soon as you can if the next scheduled dose is more than 2 days away; if it is less than 2 days away, skip it and resume on your regular day. For Zepbound®, take the missed dose as soon as possible within 4 days after the missed dose; otherwise skip it and resume on your regular day. Never double up to make up for a miss, and message your provider whenever you are unsure.

Check the liquid before each injection: Wegovy® should be clear and colorless, and Zepbound® clear and colorless to slightly yellow. Do not use it if it looks cloudy or has particles, and follow the label's storage limits.

Eating in the first month on semaglutide

Slower stomach emptying changes how eating feels, so the first month is a good time to adjust habits rather than push through them. General guidance many providers and dietitians share:

• Smaller meals, more slowly. Large meals are a common trigger for nausea. Stop when you feel satisfied, not full.
• Protein first. Protein may help preserve lean mass while losing weight and keeps you satisfied. Our protein on GLP-1 guide explains the ranges commonly cited for adults.
• Fluids all day. Reduced appetite often means reduced thirst. Water, broth and other low-sugar fluids help with constipation, headache and fatigue.
• Go easy on fatty and fried foods. They sit longer in a slower stomach and are a frequent cause of discomfort in the first weeks.
• Fiber, gradually. Vegetables, fruit and whole grains help with constipation, but adding a lot at once can cause bloating.

This is general nutrition guidance, not a meal plan. A provider or registered dietitian personalizes it to your health history. Our guide on what to eat on a GLP-1 goes into more detail.

Tirzepatide and alcohol: what to know

Neither the Wegovy® nor the Zepbound® label prohibits alcohol, and neither lists it as a drug interaction. There are still 4 practical reasons to be careful with tirzepatide and alcohol, or semaglutide and alcohol:

• Alcohol irritates the stomach and can make nausea worse, especially with a slower-emptying stomach.
• Both labels warn about low blood sugar, mainly in people who also take insulin or a sulfonylurea for diabetes. Alcohol can lower blood sugar too, so the combination raises that risk.
• Alcohol adds calories with no nutrition.
• Some patients report that they want alcohol less while on these medications; that is anecdotal, not a label effect.

The National Institute on Alcohol Abuse and Alcoholism notes that alcohol can damage the lining of the digestive tract and, in people with diabetes, can make blood sugar harder to control. If you drink, ask your provider what is reasonable for you, and message them if alcohol brings on vomiting or dizziness.

Side effects to expect and when to call

The most common side effects listed in both labels involve the digestive system: nausea, diarrhea, constipation, vomiting, stomach pain, indigestion and, for tirzepatide, injection-site reactions. For many patients these are most noticeable in the first weeks and after dose increases, then ease. Our guides on semaglutide side effects and whether tirzepatide is safe cover them in depth.

Contact your provider or seek care right away if you experience:

• Severe abdominal pain that does not go away, with or without vomiting, which can be a sign of pancreatitis.
• Pain in the upper right abdomen, fever, or yellowing of the skin or eyes, which can be signs of gallbladder problems.
• Signs of an allergic reaction such as swelling of the face, lips or throat, trouble breathing, or a severe rash.
• Vision changes, especially if you have diabetes.
• Symptoms of low blood sugar such as shakiness, sweating, confusion or a fast heartbeat.
• Vomiting or diarrhea that will not stop, or signs of dehydration such as very dark urine.
• A lump or swelling in the neck, hoarseness or trouble swallowing.
• Depression or thoughts of harming yourself.

Call 911 in an emergency. You can also report any side effect to the FDA's MedWatch program at 1-800-FDA-1088 or at www.fda.gov/medwatch.

Tracking progress you can sustain

Daily weigh-ins can mislead. Water, salt, sleep and digestion can shift the scale from one day to the next. Weigh yourself at the same time once or twice a week and watch the trend over several weeks.

Non-scale markers are often the earlier signal. Many patients notice clothes fitting differently, less food noise, fewer late-night snacks or steadier energy before the scale catches up. Write them down for your provider.

Dose increases are decided by your provider, based on how you are responding and tolerating the medication. Never adjust a dose on your own. If progress is slower than you hoped after the first month, that is information for a conversation, not a reason to stop.

What Forever Health Rx follow-up looks like

Forever Health Rx is a telemedicine platform, so follow-up runs through your patient portal. You can message your provider about side effects, injection technique or eating, and clinical messages are typically answered within . Your provider reviews your check-ins and decides whether and when to adjust the dose.

If you have not started yet, our guide to what happens in your online visit explains the process, and you can start your health assessment when ready. A licensed provider decides whether treatment is appropriate; submitting a visit does not guarantee a prescription. Details on each medication, including full safety information, are on the semaglutide and tirzepatide pages.